40 results
8-K
EX-3.1
GOSS
Gossamer Bio Inc
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
of this Corporation all rights incident to any and all securities of any other entity or entities standing in the name of this Corporation. The authority granted
424B3
GOSS
Gossamer Bio Inc
28 Aug 23
Prospectus supplement
4:29pm
of a counsel for the selling stockholders, blue sky fees and expenses and the expenses of any special audits incident to the registration.
Termination … to be made directly or through agents. We will not receive any of the proceeds from this offering.
We are required to pay all fees and expenses incident
S-3
9l995bq
18 Aug 23
Shelf registration
8:41am
S-3ASR
8v4hy 0v8
17 Aug 23
Automatic shelf registration
4:01pm
S-3ASR
ay3806cn
9 Aug 22
Automatic shelf registration
12:00am
S-3ASR
372o2ym
3 Mar 22
Automatic shelf registration
4:05pm
8-K
EX-1.1
4webaych451
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-1.2
y00gr8y6gnvxom4nl4
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
424B5
ekmz3t8o
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
fkspnjk26ilv8 66p0
19 May 20
Prospectus supplement for primary offering
5:08pm
424B5
nfv1fxr22
18 May 20
Prospectus supplement for primary offering
4:16pm
424B5
rk80550y dyrps6jok
18 May 20
Prospectus supplement for primary offering
4:11pm